CCL2 and esophageal squamous cell carcinoma: The LINC00330/CCL2 axis can block the CCL2/CCR2 axis and its downstream signaling pathways through the autocrine pathway and inhibit the secretion of CCL2 through the paracrine pathway, mediate TAM reprogramming, and inhibit ESCC progression.